Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
about
Prevalence of kidney disease in HIV-infected and uninfected Rwandan womenDeterminants of clinician knowledge on aging and HIV/AIDS: a survey of practitioners and policy makers in Kampala District, UgandaPotential impact of a free online HIV treatment response prediction system for reducing virological failures and drug costs after antiretroviral therapy failure in a resource-limited settingCombination implementation for HIV prevention: moving from clinical trial evidence to population-level effectsImpact of human immunodeficiency virus type-1 sequence diversity on antiretroviral therapy outcomesModels and impact of patient and public involvement in studies carried out by the Medical Research Council Clinical Trials Unit at University College London: findings from ten case studies.Prevalence of potential drug-drug interactions involving antiretroviral drugs in a large Kenyan cohortPregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trialSwitching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in ThailandEvidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA TrialKericho CLinic-based ART Diagnostic Evaluation (CLADE): design, accrual, and baseline characteristics of a randomized controlled trial conducted in predominately rural, district-level, HIV clinics of KenyaCost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and ZimbabweAdverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medicationInitiation of antiretroviral therapy.Redesigning the AIDS response for long-term impact.Involvement of consumers in studies run by the Medical Research Council Clinical Trials Unit: results of a survey.What are the barriers to scaling up health interventions in low and middle income countries? A qualitative study of academic leaders in implementation science.Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART.Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1-infected adults receiving antiretroviral therapy in Africa and Asia: data from the ANRS 12222 collaborationPredictors of Treatment Failure in HIV-Positive Children Receiving Combination Antiretroviral Therapy: Cohort Data From Mozambique and Uganda.Clinical impact and cost of monitoring for asymptomatic laboratory abnormalities among patients receiving antiretroviral therapy in a resource-poor setting.Implementation and Operational Research: Risk Charts to Guide Targeted HIV-1 Viral Load Monitoring of ART: Development and Validation in Patients From Resource-Limited Settings.Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population.Hepatitis B serological markers and plasma DNA concentrations.COHORT PROFILE: The Complications of Long-Term Antiretroviral Therapy study in Uganda (CoLTART), a prospective clinical cohort.HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and ZimbabweDifferentiated Human Immunodeficiency Virus RNA Monitoring in Resource-Limited Settings: An Economic AnalysisLow levels of viral suppression among refugees and host nationals accessing antiretroviral therapy in a Kenyan refugee campMeasures of viral load using Abbott RealTime HIV-1 Assay on venous and fingerstick dried blood spots from provider-collected specimens in Malawian District Hospitals.Cost-effectiveness of laboratory monitoring in sub-Saharan Africa: a review of the current literature.Recent key advances in human immunodeficiency virus medicine and implications for ChinaEvidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapyLong-term costs and health impact of continued global fund support for antiretroviral therapyScaling up global health interventions: a proposed framework for success.Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults.Cost-effectiveness of early versus standard antiretroviral therapy in HIV-infected adults in HaitiUtility of total lymphocyte count as a surrogate marker for CD4 counts in HIV-1 infected children in KenyaDiscontinuation of standard first-line antiretroviral therapy in a cohort of 1434 Malawian children.The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe
P2860
Q21034190-463323DD-A98B-413A-A2F1-A9A65AE8E033Q21133665-02CD0930-A9FB-45D9-9512-B0EF46F95BC7Q21284831-B4310561-4232-45A6-AA64-1954C5FF3C4EQ24610019-7FE7D0F1-9B1B-4F9E-A59F-88734F069AA3Q26851997-6C3752DF-71A3-4825-9C41-E7F976B33B9AQ27332376-BE58B60D-03D3-47B4-8988-B69F6AB2C1FDQ28477246-C025CE3D-2C0A-4ACB-9C4B-4BDBEDA753E6Q28483723-97739367-7AFC-419C-93FF-DDFA81C85D6CQ28535141-057919EA-F573-49FC-82EE-80774B5A6C5AQ28548288-19EDF794-347D-47C9-AE9C-960EA269D515Q28649524-B2BFADAD-C7C2-4376-B688-12997445CDC1Q28730357-5FF9077E-53CE-4883-BBFB-1BF8F948708CQ28749406-3FDAB966-47F2-4A6E-B1F9-6CA9BE3DED81Q30209635-712BB548-2874-4333-891E-82D9C3114D7BQ30409479-7A061A65-E201-44A7-8382-575CBD851F7CQ30520643-5561B118-C0CD-4CF7-87D9-E305C42D705FQ30528944-FB6C6369-3AC3-4653-9E2B-04906D4FA937Q30539434-FA6EF841-6D08-4781-A442-0E28E3FE12AEQ30558310-41037ADB-1DF6-42A4-A873-5410EA83BDCAQ30583563-67C96E88-5164-45A8-9BA1-264C41A087EFQ30997469-8C1C4FDB-FA10-41D8-BC59-0A62E8BB5714Q33390898-DBD1F06E-09AA-48AA-84DB-D0CB26FD7832Q33576031-7694EE1F-AD5B-4C9B-A2E5-6F4107183ABDQ33589777-3736A909-3823-48EF-841D-52FB464DE716Q33631046-51CBA277-5AE3-4C95-95BB-81DC5E54BE59Q33640397-20CAE027-C4A6-44AA-9186-21CAE19282F1Q33713765-959F9C0B-3EB5-4A0D-BB9D-BE78B4E92669Q33737122-86B43964-E01B-4C14-92C7-B009BC82C6F3Q33742478-44BCA2E7-6EED-4FF6-856D-6E70E4ECFEF2Q33813587-0754E38A-3DA2-4E31-9960-FF235EB327E8Q33893797-A3F6559A-981E-425F-9B0B-9CA5F800B8B4Q33933502-3713E8CB-0B00-4456-BA99-5F04F0B4B9D2Q33939760-FBA4266B-923F-4D4B-AC25-8FA4ACA6E7E3Q33952153-31457142-AC52-4EE4-9728-F7C0536C3869Q33954296-8EDFF13C-409A-4F81-A9B2-B793291423CBQ33962762-DF93618A-2DA4-40D0-BBA0-4B43CA7FFDBEQ34031173-4F8FF9BD-1D4E-4FAE-8AC8-1257278A469AQ34036174-57539F3F-ACB7-4EA4-8434-51F268646AD7Q34071404-D9F02F69-8B27-4D1E-9810-3AC1D302B95EQ34107634-B450FBD7-7F53-48D2-AE16-6D34D6A94D1E
P2860
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Routine versus clinically driv ...... ndomised non-inferiority trial
@ast
Routine versus clinically driv ...... ndomised non-inferiority trial
@en
Routine versus clinically driv ...... tiretroviral therapy in Africa
@nl
type
label
Routine versus clinically driv ...... ndomised non-inferiority trial
@ast
Routine versus clinically driv ...... ndomised non-inferiority trial
@en
Routine versus clinically driv ...... tiretroviral therapy in Africa
@nl
prefLabel
Routine versus clinically driv ...... ndomised non-inferiority trial
@ast
Routine versus clinically driv ...... ndomised non-inferiority trial
@en
Routine versus clinically driv ...... tiretroviral therapy in Africa
@nl
P2093
P2860
P1433
P1476
Routine versus clinically driv ...... ndomised non-inferiority trial
@en
P2093
A Breckenridge
A Byamukama
A Chogo Wapakhabulo
A Coutinho
A Florence
A G Babiker
P2860
P304
P356
10.1016/S0140-6736(09)62067-5
P407
P577
2009-12-08T00:00:00Z